Fidelity Investments’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
– Sell
-569,336
Closed -$7.86M – 2728
2017
Q1
$7.86M Sell
569,336
-136,364
-19% -$2.19M ﹤0.01% 2046
2016
Q4
$13.4M Hold
705,700
– – ﹤0.01% 1855
2016
Q3
$15.7M Sell
705,700
-11,000
-2% -$207K ﹤0.01% 1797
2016
Q2
$13.1M Sell
716,700
-181,700
-20% -$3.13M ﹤0.01% 1849
2016
Q1
$16.3M Hold
898,400
– – ﹤0.01% 1769
2015
Q4
$15.1M Sell
898,400
-39,159
-4% -$665K ﹤0.01% 1811
2015
Q3
$16.9M Sell
937,559
-322,317
-26% -$7.18M ﹤0.01% 1713
2015
Q2
$32.6M Buy
1,259,876
+258,100
+26% +$6.52M ﹤0.01% 1531
2015
Q1
$21.9M Buy
+1,001,776
New +$21.6M ﹤0.01% 1697

Other funds holding ENTL

Fidelity Investments's ENTL Position: Q2 2017 in Review

Fidelity Investments sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q2 2017, closing a stake of 569,336 shares — an estimated $7.86M sold.

Fidelity Investments first reported a position in ENTL in Q1 2015 and held it in 9 quarters. The position peaked at $32.6M in Q2 2015. 73 funds tracked by Wall St. Rank hold ENTL as of Q2 2017.

  • Fidelity Investments reported no remaining Entellus Medical, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Fidelity Investments sold 569,336 Entellus Medical, Inc. Common Stock shares in Q2 2017, an estimated $7.86M.
  • Fidelity Investments first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and held it in 9 quarters.
  • Fidelity Investments's Entellus Medical, Inc. Common Stock position peaked at $32.6M in Q2 2015.
  • 73 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q2 2017.

Based on Fidelity Investments's 13F filing for Q2 2017, filed 11 Aug 2017.